BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32202170)

  • 1. 532 nm Q-switched laser for the treatment of hyperpigmentation induced by topical tacrolimus.
    Deilhes F; Konstantinou MP; Lamant L; Paul C; Hautier JM; Livideanu CB
    J Cosmet Laser Ther; 2020 Feb; 22(2):90-92. PubMed ID: 32202170
    [No Abstract]   [Full Text] [Related]  

  • 2. Q-switched laser treatment of amiodarone pigmentation.
    Bernstein EF
    J Drugs Dermatol; 2011 Nov; 10(11):1316-9. PubMed ID: 22052315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Q-Switched Alexandrite Laser and Topical 20% Monobenzyl Ester of Hydroquinone Removal of Tacrolimus-Induced Repigmentation (After Complete Depigmentation With 20% Monobenzyl Ether of Hydroquinone).
    McGuinn KP; Saedi N; Green JB; Dover JS
    Dermatol Surg; 2019 May; 45(5):756-757. PubMed ID: 30893165
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed darkening of imipramine-induced hyperpigmentation after treatment with a Q-switched Nd:YAG laser followed by a Q-switched ruby laser.
    Izikson L; Anderson RR
    Dermatol Surg; 2009 Mar; 35(3):527-9. PubMed ID: 19250303
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review.
    Levin MK; Ng E; Bae YS; Brauer JA; Geronemus RG
    Lasers Surg Med; 2016 Feb; 48(2):181-7. PubMed ID: 26922302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized control study of the prevention of hyperpigmentation post Q-switched Nd:YAG laser treatment of Hori nevus using topical fucidic acid plus betamethasone valerate cream versus fucidic acid cream.
    Uaboonkul T; Nakakes A; Ayuthaya PK
    J Cosmet Laser Ther; 2012 Jun; 14(3):145-9. PubMed ID: 22471899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemosiderin Hyperpigmentation: Successful Treatment With Q-Switched 755-nm Laser Therapy.
    Gan SD; Orringer JS
    Dermatol Surg; 2015 Dec; 41(12):1443-4. PubMed ID: 26561958
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of latanoprost-induced diffuse facial skin hyperpigmentation.
    Kim HY; Lee SK; Lee JH; Suh JH; Kim MS; Lee UH
    J Cosmet Dermatol; 2019 Dec; 18(6):1717-1720. PubMed ID: 30924263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of exogenous hyperpigmentary disorders following silver ion-related chemical exposure with 1,064nm Q-switched laser: a 10-year follow-up.
    Feng J; Huang L
    J Cosmet Laser Ther; 2022 Nov; 24(6-8):107-109. PubMed ID: 36093629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of 532-nm Q-switched Nd:YAG laser for smoker's gingival hyperpigmentation.
    Cho SB; Lee JH; Seo W; Bang D
    J Cosmet Laser Ther; 2010 Apr; 12(2):77-80. PubMed ID: 20331344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous siderosis secondary to intramuscular iron dextran treated with 755 nm Q-switched alexandrite laser: A case report.
    Lloyd AA; Graves MS; Ross EV
    Lasers Surg Med; 2015 Jul; 47(5):386-7. PubMed ID: 25994768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal pigmentation after oral lichen planus treatment with topical tacrolimus.
    Fricain JC; Sibaud V; Campana F; Lepreux S; Taïeb A
    Dermatology; 2005; 210(3):229-32. PubMed ID: 15785053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete resolution of minocycline pigmentation following a single treatment with non-ablative 1550-nm fractional resurfacing in combination with the 755-nm Q-switched alexandrite laser.
    Vangipuram RK; DeLozier WL; Geddes E; Friedman PM
    Lasers Surg Med; 2016 Mar; 48(3):234-7. PubMed ID: 26718463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-fluence Q-switched Nd:YAG 1064-nm laser versus Q-switched Nd:YAG 532-nm laser in the treatment of hyperpigmented lips: a prospective, randomized, controlled, evaluator-blinded trial.
    Limpjaroenviriyakul N; Jurairattanaporn N; Kamanamool N; Rojhirunsakool S; Kanokrungsee S; Udompataikul M
    Lasers Med Sci; 2020 Feb; 35(1):165-171. PubMed ID: 31177406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective treatment of psychotropic drug-induced facial hyperpigmentation with a 755-nm Q-switched alexandrite laser.
    Wee SA; Dover JS
    Dermatol Surg; 2008 Nov; 34(11):1609-12. PubMed ID: 19021670
    [No Abstract]   [Full Text] [Related]  

  • 16. Q-switched double-frequency Nd:YAG (532 nm) laser is an effective treatment for racial lip pigmentation.
    Alharbi MA
    J Cosmet Dermatol; 2019 Dec; 18(6):1672-1674. PubMed ID: 30964234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Picosecond alexandrite laser is superior to Q-switched Nd:YAG laser in treatment of minocycline-induced hyperpigmentation: A case study and review of the literature.
    Barrett T; de Zwaan S
    J Cosmet Laser Ther; 2018; 20(7-8):387-390. PubMed ID: 29400580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of minocycline-induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literature.
    Green D; Friedman KJ
    J Am Acad Dermatol; 2001 Feb; 44(2 Suppl):342-7. PubMed ID: 11174411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the Q-switched Nd:YAG laser for the treatment of pigmentary disorders in Egyptians.
    Salem A; El Harras M; Ramadan A; Gamil H; Rahman AA; El-Said K
    J Cosmet Laser Ther; 2010 Apr; 12(2):92-100. PubMed ID: 20331347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful laser treatment of vandetanib-associated cutaneous pigmentation.
    Brooks S; Linehan WM; Srinivasan R; Kong HH
    Arch Dermatol; 2011 Mar; 147(3):364-5. PubMed ID: 21422355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.